Local Expression of Corticotropin‐Releasing Hormone in Inflammatory Arthritis

Annals of the New York Academy of Sciences

Volumn 771, Issue 1, 1995, Pages 459-471

  CROFFORD, LESLIE J ^a   SANO, HAJIME ^b   KARALIS, KATIA ^c   WEBSTER, ELIZABETH A ^d   FRIEDMAN, THEODORE C ^d   CHROUSOS, GEORGE P ^d   WILDER, RONALD L ^e  

^a UNIVERSITY OF MICHIGAN   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CORTICOTROPIN RELEASING FACTOR; PREPROTACHYKININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; CONFERENCE PAPER; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE SYSTEM; JOINT; NONHUMAN; RAT; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM;

EID: 0029551754     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1995.tb44702.x     Document Type: Article

References (63)

1. Interleukin‐1 stimulates the secretion of hypothalamic corticotropin releasing factor
2. Corticotropin‐releasing factor producing neurons in the rat activated by interleukin‐1
3. Interleukin‐6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely‐moving rats
4. The alkyl‐ether phospholipid platelet‐activating factor is a stimulator of the hypothalamic‐pituitary‐adrenal axis in the rat
5. Interleukin‐1 stimulates corticotropin‐releasing factor gene expression in rat hypothalamus
6. The effects of recombinant human interleukin (IL)‐1α, IL‐1β, or IL‐6 on hypothalamo‐pituitary‐adrenal axis activation
7. Corticotropin‐releasing factor‐like immunoreactivity and mRNA in human leukocytes
8. Biosynthesis of corticotropin‐releasing hormone in human T‐lymphocytes
9. Immuno‐reactive and bioactive corticotropin‐releasing factor in rat thymus
10. 125I]corticotropin‐releasing factor to blood immunocytes and its reduction in Alzheimer's disease
11. Receptor‐mediated immunomodulation by corticotropin‐releasing factor
12. Corticotropin‐releasing factor receptors in mouse spleen: identification of receptor‐bearing cells as resident macrophages
13. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors
14. Stimulation of interleukin‐6 production by corticotropin‐releasing factor
15. Enhancing effect of corticotropin‐releasing neurohormone on the production of interleukin‐1 and interleukin‐2
16. Immunosuppressive activity of cortico‐trophin‐releasing factor: inhibition of interleukin‐1 and interleukin‐6 production by human mononuclear cells
17. Stimulatory effect of corticotropin‐releasing neurohormone on human lymphocyte proliferation and interleukin‐2 receptor expression
18. Modulation of natural killer cell‐mediated lysis by corticotropin‐releasing neurohormone
19. The role of IL‐1 in the corticotropin‐releasing factor and arginine‐vasopressin‐induced secretion of immunoreactive β‐endorphin by human peripheral blood mononuclear cells. J
20. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin
21. The contribution of the nervous system to inflammation and inflammatory disease
22. Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis
23. Substance P in sensory nerve fibers contributes to the development of oedema in the rat hind paw after thermal injury
24. Inhibition of carrageenan‐induced joint inflammation by substance P antagonist
25. Capsaicin depletes corticotropin‐releasing factor‐like immunoreactive neurons in the medulla oblongata and spinal cord
26. Immunocytochemical localization of corticotropin releasing factor (CRF) in the rat spinal cord
27. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis
28. Neural control of vascular permeability: interactions between primary afferents, mast cells, and sympathetic efferents
29. Autocrine or paracrine inflammatory actions of corticotropin‐releasing hormone in vivo
30. Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception
31. Posttranslational processing of corticotropin‐releasing factor in the ovine tuberoinfundibular system and pituitary
32. The immune‐hypothalamic‐pituitary‐adrenal axis
33. Corticotropin‐releasing factor inhibits neurogenic plasma extravasation in the rat paw
34. Peripheral anti‐inflammatory actions of corticotropin‐releasing factor
35. CRH: an inhibitor of neurogenic plasma extravasation produced by saphenous nerve stimulation
36. Strain and sex variation in the susceptibility to streptococcal cell wall‐induced polyarthritis in the rat
37. Thymus‐dependent and ‐independent regulation of Ia antigen expression in situ by cells in synovium of rats with streptococcal cell wall‐induced arthritis. Differences in site and intensity of expression in euthymic, athymic, and cyclosporin A‐treated LEW and F344 rats
38. Streptococcal cell wall‐induced polyarthritis in rats
39. Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. In situ localization and kinetics of expression of the transformation‐associated metalloproteinase in euthymic and athymic Lewis rats
40. Detection of high levels of heparin binding growth factor‐1 (acidic fibroblast growth factor) in inflammatory arthritic joints
41. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis
42. Local secretion of corticotropin‐releasing hormone in the joints of Lewis rats with inflammatory arthritis
43. Studies of polyarthritis and other lesions induced in rats by injection of Mycobacterial adjuvant. I. General clinical and pathologic characteristics and some modifying factors
44. Diversity in mammalian tackykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms
45. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
46. Coexpression of phosphotyrosine‐containing proteins, PDGF‐B and FGF‐1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis
47. Transin/stromelysin expression in rheumatoid synovium: a transformation‐associated metalloproteinase secreted by phenotypically invasive synoviocytes
48. Corticotropin‐releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis
49. Presence of corticotropin releasing factor‐like immunoreactivity in hypophyseal portal blood
50. Chronic activation of the hypothalamo‐pituitary‐adrenal axis and loss of circadian rhythm during adjuvant‐induced arthritis in the rat
51. Paradoxical responses of hypothalamic corticotropin‐releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF‐41 peptide and adenohypophysial proopio‐melanocortin mRNA during chronic inflammatory stress
52. Influence of steroids on the hypothalamic corticotropin‐releasing factor and preproenkephalin mRNA responses to stress
53. Differential regulation of corticotropin‐releasing hormone mRNA in rat brain
54. Multiple feedback regulatory loops upon rat hypothalamic corticotropin‐releasing hormone secretion
55. Neurotransmitter‐induced hypothalamic‐pituitary‐adrenal axis responsiveness in inflammatory disease‐susceptible Lewis rats: in vivo and in vitro studies suggesting a global defect in CRH secretion
56. Intracerebroventricular injection of platelet‐activating factor induces secretion of adrenocorticotropin, beta‐endorphin and corticosterone in conscious rats: a possible link between the immune and nervous systems
57. Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis
58. Substance P and arthritis: analysis of plasma and synovial fluid levels
59. Substance P and somatostatin levels in rheumatoid arthritis, osteoarthritis, and psoriatic arthritis synovial fluid
60. Nerve growth factor in the synovial fluid of patients with chronic arthritis
61. Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis
62. Hypothesis: a neurogenic mechanism for symmetrical arthritis